Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2010-10-29

Clinical Trial Update: TRAUMEEL for Pain After Fracture of Neck of Femur [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating TRAUMEEL for pain after fracture of the neck of the femur has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAUMEEL

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Pain, Fracture of Neck of Femur | Phase 3 | Status: WITHDRAWN